ACIST CVi™ KNOWLEDGE LEADERSHIP

Perspectives on the ACIST CVi™
Contrast Delivery System:
Dr. Mark Rothenberg, MD, FACC
Medical Director, Cardiac Catheterization Laboratory
JFK Medical Center | West Palm Beach, FL

About Dr. Rothenberg:
Dr. Rothenberg focuses oninterventional cardiology,
specifically coronary arterydisease and valvular
heart disease.
Dr. Rothenberg completed
a 6 year medical programat Lehigh University andthe Medical College ofPennsylvania in 1989. Hecompleted his medical
internship and residency at
Temple University Hospitalin 1992, and completed
a cardiology fellowship at
Temple University Hospitalin 1996. He has been atJFK Medical Center
since 1999.

Contrast delivery has been an important concern for
Dr. Rothenberg since he began his interventional cardiology
career over 20 years ago. Throughout his practice, manyof his patients have been elderly with compromised renal
function—thus at greater risk for CI-AKI.
As a proctor for transcatheter aortic valve replacement (TAVR),
Dr. Rothenberg is also keenly interested in anything that helps
advance this alternative to open heart surgery. We asked
Dr. Rothenberg for his insights on the value ACIST CVi bringsto his patients, clinicians and hospital systems.

Do you use CVi every time you perform a TAVR
(also called TAVI)?
CVi is in four of my five hospitals. Of those four that have CVi, it’s used for
all coronary cases in all of the rooms. I use CVi for TAVR; my partner uses
CVi for our peripheral cases. We adopted CVi years ago and my practicepartners and I wouldn’t think of not using it whenever it’s available to us.

Why did those four hospitals implement CVi?
Hospital administration leadership was able to see from the studies thatCVi delivers significant measurable benefits, from patient and staff safety
to contrast savings and improvement in turnover time.

Of those benefits, which do you think are most important?
That’s hard to say, it’s such a great device in so many ways. As a proctor,
I appreciate that CVi helps mitigate challenges that can be part of performing
TAVR. For example, there are times when your first aortogram doesn’t reveal
the aortic sinuses as well as you would like. With CVi, it just takes a puff ofcontrast to know all you need to know.
continued >You can inject under pressure, which is important because a lot of cases
involve high-flow coronary arteries. There’s no need to turn multiple
stopcocks, as there is with the manifold system. CVi simply gives you
far more confidence in minimizing the amount of contrast you need.
In terms of benefits for my patients, hands down it’s the protection CVi
delivers against CI-AKI. That’s invaluable.

Why isn’t CVi in that fifth location?
That hospital has not made the evolution from manifold. It’s more difficult
to perform cases at that site (they don’t do TAVRs there). It reminds me
what life was like before CVi—all the chronic hand soreness that comesfrom using a manual system every day.
When I proctor for TAVR, I’m relieved when I see the ACIST CVi. It’s
increasingly the standard. In fact, for one of the hospitals that uses CVi, it
started in one cath lab. It didn’t take long to get it in three more cath labs,
the hybrid OR and the interventional radiology suite.

What would most surprise someone who hasn’t used CVi?
How easy it is to use and adopt. There’s really no learning curve in using
it. The staff requires some training to ensure efficient setup so there’s nodowntime. But each site gets up to speed fast. You have to get it in yourhands to believe how intuitive it is.

With two decades of experience, what changes have you seen
in your field?
I used to feel like a golfer, working alone for the benefit of my patients.
Now it’s like I’m a baseball player - part of an important team made up
of other players, medical device reps and cath lab staff, all working together
and sharing perspectives to bring value to each procedure.
I feel fortunate to be in interventional cardiology. It’s constantly evolving. CVi
has helped every step of the way to make TAVR and other procedures safer
for patients, safer and easier for the cath lab (or hybrid) team and me, andmore economically viable than the alternative for the hospitals.

Bracco Group© 2020 ACIST Medical Systems, Inc. All Rights Reserved. P/N: 30-100091_US 06/20 Rev 1